Cambridge, Massachusetts
United States
117
2015-01-22
85
2017-09-12
These are the the leading inventors for applications assigned to DYAX CORP.:
DYAX CORP. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ANTI MIF ANTIBODIES
#2 | 2014-09-25 β Patent 9,757,437 granted on 2017-09-12Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#3 | 2014-08-07 β Patent 9,156,883 granted on 2015-10-13Binding molecules for human factor VIII and factor VIII-like proteins
#4 | 2014-07-24 β Patent 9,056,138 granted on 2015-06-16Multivalent constructs for therapeutic and diagnostic applications
#5 | 2013-03-28 β Patent 8,815,246 granted on 2014-08-26Fc receptor binding proteins
#6 | 2013-01-10 β Patent 8,716,225 granted on 2014-05-06Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#7 | 2012-12-27 β Patent 8,663,629 granted on 2014-03-04Kallikrein-binding βkunitz domainβ proteins and analogues thereof
#8 | 2012-08-09 β Patent 8,816,055 granted on 2014-08-26Plasma kallikrein binding proteins
#9 | 2012-06-07 β Patent 8,501,181 granted on 2013-08-06Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
#10 | 2012-05-03 β Patent 9,051,377 granted on 2015-06-09Method for treating breast cancer using antibody binding to MMP-14
#11 | 2012-02-23 β Patent 8,535,892 granted on 2013-09-17Binding molecules for human factor VIII and factor VIII-like proteins
#12 | 2012-02-02 β Patent 8,399,384 granted on 2013-03-19Focused libraries of genetic packages
#13 | 2012-02-02 β Patent 8,455,205 granted on 2013-06-04Metalloproteinase 9 binding proteins
#14 | 2012-02-02HK1-BINDING PROTEINS
#15 | 2012-01-19 β Patent 9,114,144 granted on 2015-08-25Kallikrein-inhibitor therapies
#16 | 2011-12-22 β Patent 9,000,124 granted on 2015-04-07Peptides that specifically bind HGF receptor (cMet) and uses thereof
#17 | 2011-12-08METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS
#18 | 2011-11-24 β Patent 9,040,258 granted on 2015-05-26Multi-chain eukaryotic display vectors and uses thereof
#19 | 2011-11-17 β Patent 9,068,980 granted on 2015-06-30Multi-chain eukaryotic display vectors and uses thereof
#20 | 2011-11-17 β Patent 9,116,149 granted on 2015-08-25Multi-chain eukaryotic display vectors and uses thereof
#21 | 2011-10-27USE OF IGF-II/IGF-IIE BINDING PROTEINS FOR THE TREATMENT AND PREVENTION OF SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY FIBROSIS
#22 | 2011-10-27COMBINATION TREATMENTS COMPRISING PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISORDERS
#23 | 2011-09-01 β Patent 8,247,185 granted on 2012-08-21Conformation specific antibodies
#24 | 2011-08-18 β Patent 8,822,653 granted on 2014-09-02Plasma kallikrein binding proteins
#25 | 2011-08-04 β Patent 9,005,927 granted on 2015-04-14Multi-chain eukaryotic display vectors and uses thereof
#26 | 2011-07-14Poly-Pegylated Protease Inhibitors
#27 | 2011-07-14 β Patent 9,388,510 granted on 2016-07-12Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs
#28 | 2011-06-23INHIBITORS OF HUMAN PLASMIN DERIVED FROM THE KUNITZ DOMAINS
#29 | 2011-06-09 β Patent 8,283,321 granted on 2012-10-09Kallikrein-binding βKunitz domainβ proteins and analogues thereof
#30 | 2011-06-09METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS
#31 | 2011-04-14 β Patent 8,710,007 granted on 2014-04-29Prevention and reduction of blood loss
#32 | 2011-04-07LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR3 DESIGNS
#33 | 2011-03-24 β Patent 8,663,603 granted on 2014-03-04Multivalent constructs for therapeutic and diagnostic applications
#34 | 2011-03-10TIE COMPLEX BINDING PROTEINS
#35 | 2011-01-13 β Patent 8,748,368 granted on 2014-06-10Methods for preserving organs and tissues
#36 | 2010-11-18 β Patent 8,058,017 granted on 2011-11-15Methods and compositions for purifying human factor VIII, factor VIII-like proteins or fragments thereof
#37 | 2010-11-18 β Patent 8,895,475 granted on 2014-11-25Focused libraries of genetic packages
#38 | 2010-11-18METALLOPROTEINASE-BINDING PROTEINS
#39 | 2010-10-28 β Patent 9,107,928 granted on 2015-08-18Compositions and methods for treating ophthalmic disorders
#40 | 2010-10-21 β Patent 8,691,225 granted on 2014-04-08Antibodies against the ectodomain of ErbB3 and uses thereof
#41 | 2010-10-21 β Patent 8,106,168 granted on 2012-01-31Metalloproteinase binding proteins
#42 | 2010-10-14 β Patent 8,044,175 granted on 2011-10-25Peptides that specifically bind HGF receptor (CMET) and uses thereof
#43 | 2010-10-14 β Patent 8,668,909 granted on 2014-03-11Anti MIF antibodies
#44 | 2010-10-14PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOF
#45 | 2010-08-05Method of inhibition of vascular development using an antibody
#46 | 2010-07-22 β Patent 8,637,454 granted on 2014-01-28Treatment of mucositis with kallikrein inhibitors
#47 | 2010-03-04ANTIBODIES AGAINST ERBB3 AND USES THEREOF
#48 | 2009-12-31 β Patent 8,273,351 granted on 2012-09-25Fc receptor binding proteins
#49 | 2009-12-17 β Patent 8,008,445 granted on 2011-08-30Metalloproteinase 9 binding proteins
#50 | 2009-12-17 β Patent 8,114,968 granted on 2012-02-14Metalloproteinase-12 specific monoclonal antibody
#51 | 2009-12-03 β Patent 8,013,125 granted on 2011-09-06Metalloproteinase 9 and metalloproteinase 2 binding proteins
#52 | 2009-11-05Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
#53 | 2009-10-01Kallikrein Inhibitors and Anti-thrombolytic Agents and Uses Thereof
#54 | 2009-09-17 β Patent 7,893,007 granted on 2011-02-22Directed evolution of novel binding proteins
#55 | 2009-09-17Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#56 | 2009-09-17Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#57 | 2009-09-10Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#58 | 2009-09-10Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#59 | 2009-09-03Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#60 | 2009-08-27METHODS FOR PRODUCING SPECIFIC BINDING PAIRS
#61 | 2009-08-13 β Patent 8,183,008 granted on 2012-05-22Evaluating MMP expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer
#62 | 2009-07-23 β Patent 8,147,836 granted on 2012-04-03Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
#63 | 2009-06-25 β Patent 8,288,322 granted on 2012-10-16Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
#64 | 2009-03-26 β Patent 7,811,991 granted on 2010-10-12Prevention and reduction of blood loss
#65 | 2009-02-05 β Patent 7,919,462 granted on 2011-04-05Inhibitors of human plasmin derived from the Kunitz domains
#66 | 2009-02-05INHIBITORS OF HUMAN PLASMIN DERIVED FROM THE KUNITZ DOMAINS
#67 | 2008-11-06Albumin-Fused Kunitz Domain Peptides
#68 | 2008-10-16TIE1-BINDING LIGANDS
#69 | 2008-09-11Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#70 | 2008-09-04COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#71 | 2008-09-04 β Patent 7,993,646 granted on 2011-08-09HK1-binding proteins
#72 | 2008-08-21 β Patent 7,851,442 granted on 2010-12-14Prevention and reduction of blood loss
#73 | 2008-08-07Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#74 | 2008-07-31INHIBITORS OF HUMAN PLASMIN DERIVED FROM THE KUNITZ DOMAINS
#75 | 2008-07-03SEQUENTIAL COMBINATION THERAPY
#76 | 2008-06-12 β Patent 8,034,775 granted on 2011-10-11Kallikrein-inhibitor therapies
#77 | 2008-03-27 β Patent 8,124,586 granted on 2012-02-28Prevention and reduction of blood loss
#78 | 2008-02-28 β Patent 7,718,617 granted on 2010-05-18Methods for preserving organs and tissues
#79 | 2007-11-08DIRECTED EVOLUTION OF NOVEL BINDING PROTEINS
#80 | 2007-10-25 β Patent 7,276,480 granted on 2007-10-02Prevention and reduction of blood loss
#81 | 2007-09-20 β Patent 7,745,587 granted on 2010-06-29Antibodies that bind MMP-14
#82 | 2007-07-26 β Patent 7,910,088 granted on 2011-03-22Multivalent constructs for therapeutic and diagnostic applications
#83 | 2007-07-17 β Patent 7,244,592 granted on 2007-07-17Ligand screening and discovery
#84 | 2007-05-10 β Patent 7,612,179 granted on 2009-11-03antibodies binding to a C-terminal fragment of apoliopoprotein E
#85 | 2007-05-01 β Patent 7,211,240 granted on 2007-05-01Multivalent constructs for therapeutic and diagnostic applications
#86 | 2007-05-01 β Patent 7,211,395 granted on 2007-05-01Serum albumin binding moieties
#87 | 2007-04-24 β Patent 7,208,293 granted on 2007-04-24Directed evolution of novel binding proteins
#88 | 2007-03-01 β Patent 7,704,949 granted on 2010-04-27Kallikrein-inhibitor therapies
#89 | 2007-02-22 β Patent 7,550,427 granted on 2009-06-23Poly-pegylated protease inhibitors
#90 | 2007-01-23 β Patent 7,166,576 granted on 2007-01-23Methods for preserving organs and tissues
#91 | 2007-01-04 β Patent 7,329,737 granted on 2008-02-12Antibodies that bind hK-1
#92 | 2006-11-23 β Patent 7,628,983 granted on 2009-12-08Kallikrein-binding βKunitz domainβ proteins and analogues thereof
#93 | 2006-10-10 β Patent 7,118,879 granted on 2006-10-10Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material
#94 | 2006-10-10 β Patent 7,118,872 granted on 2006-10-10Binding polypeptides for B lymphocyte stimulator protein (BLyS)
#95 | 2006-09-26 β Patent 7,112,438 granted on 2006-09-26Binding molecules for human factor VIII and factor VIII-like proteins
#96 | 2006-08-31 β Patent 7,691,565 granted on 2010-04-06Binding molecules for human factor VIII and factor VIII-like proteins
#97 | 2006-07-18 β Patent 7,078,383 granted on 2006-07-18ITI-D1 Kunitz domain mutants as HNE inhibitors
#98 | 2006-07-11 β Patent 7,074,560 granted on 2006-07-11Purification of tissue plasminogen activator (tPA)
#99 | 2006-06-22ITI-D1 Kunitz domain mutants as hNE inhibitors
#100 | 2006-06-20 β Patent 7,064,107 granted on 2006-06-20Prevention and reduction of blood loss
Also check out DYAX CORP.'s (Cambridge, United States) applicant profile with 3 patent applications submitted.
74003 β